Brief: Relief Therapeutics Signs Binding Term Sheet With Applied Pharma Research (APR) To Buy All APR's Outstanding Shares
May 4 (Reuters) - RELIEF THERAPEUTICS HOLDING SA RLFB.S :
* RELIEF AND APPLIED PHARMA RESEARCH (APR) SIGN BINDING TERM
SHEET
FOR RELIEF TO ACQUIRE ALL OUTSTANDING SHARES OF APR
* ACCORDING TO TERM SHEET, APR SHAREHOLDERS WILL RECEIVE
FROM
RELIEF AT CLOSING OF A SIGNED TRANSACTION, CHF 22 MILLION IN
CASH, PLUS ADDITIONAL CASH RELATING TO APR'S WORKING CAPITAL
POSITION AT TIME OF CLOSE, AND CHF 50 MILLION PAYABLE IN RELIEF
COMMON REGISTERED SHARES.
Further company coverage: RLFB.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on MindMaze Therapeutics Holding SA
See all newsBrief: Mindmaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
Brief: Relief Therapeutics Shareholders Approve Business Combination With Neurox
Brief: Relief Therapeutics Receives FDA Response To Qidp Request For Rlf-Td011
Brief: Relief Therapeutics Says Interim CEO Michelle Lock Has Completed Her Transitional Mandate
Swiss stocks - Factors to watch on May 13